Video-assisted Thoracoscopic Thymectomy Versus Subxiphoid Procedure

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Clinical Trial Summary

Surgerys used in thymectomy for myasthenia gravis and anterior mediastinal tumours have become much less invasive in recent years. In our study, the surgical technique which resected the thymus below the xiphoid process and the technique which was regarded as conventional video- assisted thoracoscopic surgery (VATS) thymectomy was compared.

See also
	Status	Clinical Trial	Phase
	Recruiting	`NCT05262582` - Comparison of Single Port and Two Ports Robotic Assisted Thoracic Surgery for Thymectomy	N/A
	Recruiting	`NCT02317224` - The Safety and Efficacy of "3-Hole" Subxiphorid Approach in the Treatment of Anterior Mediastinal Tumor	Phase 2

NCT number	NCT04223466
Study type	Interventional
Source	The Second Hospital of Shandong University
Contact	Yunpeng Zhao
Phone	+8618766188692
Email	zyp_baggio@163.com
Status	Recruiting
Phase	N/A
Start date	January 7, 2020
Completion date	December 31, 2027

Video-assisted Thoracoscopic Thymectomy Versus Subxiphoid Procedure

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms